Exploring factors that impact uptake of risk-reducing bilateral salpingo-oophorectomy (RRBSO) in high-risk women

M Hickey; I Rio; A Trainer; JL Marino; CD Wrede; M Peate

Journal article

Exploring factors that impact uptake of risk-reducing bilateral salpingo-oophorectomy (RRBSO) in high-risk women

M Hickey, I Rio, A Trainer, JL Marino, CD Wrede, M Peate

Menopause | LIPPINCOTT WILLIAMS & WILKINS | Published : 2020

DOI: 10.1097/GME.0000000000001422

Abstract

Objective:Only risk-reducing bilateral salpingo-oophorectomy (RRBSO) has been shown to reduce ovarian cancer deaths in high-risk women. Uptake of RRBSO is, however, suboptimal and reasons are not well defined. More information is needed about the barriers to RRBSO and patient needs for information and care.Methods:Cross-sectional study including the Perception of Cancer Risk Scale, factors affecting decision-making about RRBSO, and unmet information needs were measured using a purpose-designed questionnaire.Results:Of the 193 high-risk women aged 30 to 50 approached, 60 (31%) agreed to participate. Respondents were either considering or had recently undergone premenopausal RRBSO. Most (49/60..

View full abstract

University of Melbourne Researchers

Martha Hickey Author

Alison Trainer Author

Jennifer Marino Author

Michelle Peate Author

Related Projects (2)

A CENTRE OF RESEARCH EXCELLENCE IN ADOLESCENT HEALTH: MAKING HEALTH SERVICES WORK FOR ADOLESCENTS IN A DIGITAL AGE

Developmentally appropriate adolescent healthcare must be inter-disciplinary, with sound communication and acknowledging increasing autonomy..

DEVELOPMENT AND EVALUATION OF A LOW-LITERACY DECISION AID ABOUT REPRODUCTIVE CHOICES FOR YOUNGER WOMEN WITH BREAST CANCER

Grants

Awarded by Stand Up To Cancer

Funding Acknowledgements

This study was funded by the Western and Central Melbourne Integrated Cancer Service (WCMICS). MH is funded by a National Health and Medical Research Council of Australia (NHMRC) Practitioner Fellowship and is part of the Women Choosing Surgical Prevention (WISP) investigator team funded by Stand Up to Cancer. JM is supported by NHMRC CRE 1134894 and Project Grant 1161445. MP is currently supported by a University of Melbourne MDHS Fellowship, and at the time of the study was supported through a NBCF (ECF-015) Fellowship.